Cointime

Tobira Therapeutics

company

About

Tobira Therapeutics is engaged in research and development of compounds for treating life-threatening and life-altering infectious diseases.

  • 1 - 10

Highlights

Total Funding Amount
$13M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Convertable Note
Last Funding Money Raised
$13M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$13M
Tobira Therapeutics has raised a total of $13M in funding over 2 rounds. Their latest funding was raised on Mar 9, 2015 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 9, 2015 Convertable Note $13M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Tobira Therapeutics is funded by 1 investors. Stonepine Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Stonepine Capital — Convertable Note
Cointime
เนื้อหา
บริษัท